A uric acid level of 680μmol/L, whether for men or women, is a significantly elevated state and is a relatively serious condition. The normal uric acid level should not exceed 420μmol/L for men and 360μmol/L for women. 680μmol/L uric acid needs to be treated actively to avoid diseases such as gouty arthritis and uric acid stones. Hyperuricemia is closely related to metabolic syndrome, diabetes, hypertension, gout, heart disease, cerebrovascular disease and chronic kidney disease. Elevated uric acid levels are a risk factor for the occurrence, development and death of the above diseases, and for every 60μmol/L increase in uric acid in the normal range upwards, the risk of death from coronary heart disease increases by 12%, the risk of diabetes increases by 17% and the risk of hypertension increases by 13%. Because elevated blood uric acid is deposited in the joints, it can cause gouty arthritis and joint deformation, and in the kidneys it can lead to gouty nephropathy, uric acid stones, and even uremia. Uric acid also stimulates arterial blood vessel walls, leading to atherosclerosis and inducing or aggravating coronary heart disease and cerebrovascular disease. It may also damage pancreatic beta cells and induce or aggravate diabetes. Therefore, the elevation of uric acid level of 680μmol/L is relatively large and serious. For all asymptomatic patients with hyperuricemia, lifestyle improvements should be actively pursued and uric acid-elevating drugs should be avoided. It is important to limit a diet high in purines, such as animal offal, seafood, and soy products, and especially to avoid alcohol, such as beer, liquor, and other alcoholic beverages, as well as to control weight and drink more water. If the uric acid is 680 μmol/L and the patient is already symptomatic or has a combination of underlying diseases, immediate drug treatment is required. The drugs often chosen are benzbromarone, allopurinol, sodium bicarbonate, etc. The appropriate treatment plan should be chosen after a thorough evaluation by a doctor.